Global advocacy has been successful in mobilising attention to antimicrobial resistance (AMR) by governments and agencies worldwide. Indeed, in the past decade, there has been a steady flow of reports, action plans, declarations, initiatives, and resolutions on what should be done. Inadequate access to antimicrobials and AMR are formidable threats to both human and animal health. The World Economic Forum’s annual meeting in Davos (Jan 21–25) will raise the profile of AMR again, but has this global advocacy translated into global action? In a word, no.
Read more in this Lancet editorial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30119-7/fulltext
Lancet.pdf (203.3 KB)